Summary
This D.C. Circuit opinion reviews challenges to the Environmental Protection Agency’s 2024 Rule, which establishes an allowance allocation methodology for hydrofluorocarbons (HFCs) under the American Innovation and Manufacturing Act. Petitioners argued that the Act unconstitutionally delegates legislative power to the EPA and that the agency arbitrarily excluded 2020 and 2021 market data from its historical baseline calculations. The court denied both petitions, holding that Congress provided an intelligible principle guiding the EPA’s discretion and that the agency’s methodological choices were reasonable and supported by the record.
Topics
Practice areas
Questions Presented
- Whether Choice had standing to challenge the AIM Act's delegation of authority to the EPA to allocate HFC allowances.
- Whether subsection (e)(3) of the AIM Act unconstitutionally delegates legislative power to the EPA in violation of Article I's nondelegation doctrine.
- Whether the EPA acted arbitrarily and capriciously by excluding 2020 data from its methodology for calculating HFC allowance allocations.
- Whether IGas adequately preserved its argument that the EPA should have considered 2020 data separately from 2021 data.
Holdings
- Choice had standing to challenge the constitutionality of AIM Act subsection (e)(3) because the interrelated provisions of subsection (e) were not severable: the prohibition on producing or consuming HFCs without allowances could not operate without the EPA's authority to allocate allowances.
- The AIM Act does not unconstitutionally delegate legislative power because its text, structure, purpose, and history provide an intelligible principle and sufficiently constrain the EPA's discretion in allocating HFC allowances.
- IGas adequately preserved an argument that the EPA should consider 2020 data separately from 2021 data because its comments identified distinct reasons why the agency's stockpiling concern did not apply equally to the two years.
- The EPA reasonably excluded 2020 data from its allowance-allocation methodology, and its decision was not arbitrary and capricious.
Key quotations
“The AIM Act does not unconstitutionally delegate legislative power because it sufficiently constrains the EPA’s discretion to allocate HFC allowances.” (12)
“The AIM Act’s allocation provisions, read in context, are constitutionally sufficient and do not violate the nondelegation doctrine.” (18)
“Applying that deferential standard of review, the EPA’s decision to exclude the 2020 data from its allocation methodology was not arbitrary and capricious because the agency reasonably concluded that (1) the data was unrepresentative of market share, and (2) its inclusion would disrupt the market.” (23)
Factual background
The AIM Act requires an 85 percent reduction in U.S. production and consumption of hydrofluorocarbons by 2036 through an EPA-administered cap-and-trade program. The EPA's Framework Rule for 2022 and 2023 and its 2024 Rule for 2024 through 2028 allocated allowances based on historical market share, calculated using entities' three highest years from 2011 through 2019. IGas argued that the EPA should include 2020 data, but the EPA concluded that the COVID-19 pandemic, supply-chain disruptions, possible stockpiling, and concerns about market disruption made 2020 data unrepresentative or unsuitable.
Procedural history
The EPA promulgated the 2024 Rule establishing an allowance-allocation methodology based on entities' three highest years of production or consumption from 2011 through 2019. Choice challenged the rule and the AIM Act's delegation of authority on nondelegation grounds, while IGas challenged the exclusion of 2020 data as arbitrary and capricious. The petitions were timely filed and consolidated, and two trade associations intervened in support of the EPA. The court denied both petitions for review.